NISA INVESTMENT ADVISORS, LLC - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 127 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,231
-58.7%
1,1500.0%0.00%
Q2 2023$2,979
+59480.0%
1,150
-6.0%
0.00%
Q1 2023$5
-66.7%
1,224
-58.6%
0.00%
Q4 2022$15
-99.8%
2,953
+156.8%
0.00%
Q3 2022$6,000
-70.0%
1,150
-24.5%
0.00%
Q2 2022$20,000
+233.3%
1,524
+307.5%
0.00%
Q1 2022$6,000
-94.5%
374
-94.6%
0.00%
-100.0%
Q4 2021$109,000
+78.7%
6,921
+139.6%
0.00%
Q3 2021$61,000
-69.3%
2,889
-71.4%
0.00%
-100.0%
Q2 2021$199,000
-15.3%
10,099
+24.7%
0.00%0.0%
Q1 2021$235,000
-4.1%
8,0990.0%0.00%
-50.0%
Q4 2020$245,000
+421.3%
8,099
+175.3%
0.00%
Q3 2020$47,000
-60.8%
2,942
-51.7%
0.00%
-100.0%
Q2 2020$120,000
+66.7%
6,091
+3.9%
0.00%0.0%
Q1 2020$72,000
-33.3%
5,8630.0%0.00%0.0%
Q4 2019$108,000
+33.3%
5,8630.0%0.00%0.0%
Q3 2019$81,0005,8630.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Column Group LLC 18,136,735$237,228,00052.50%
Ponoi II Management, LLC 1,298,908$16,990,00044.41%
Ponoi Management, LLC 1,298,908$16,990,00023.20%
Euclidean Capital LLC 746,674$9,766,0009.07%
StepStone Group LP 1,573,357$20,580,0002.93%
Logos Global Management LP 850,000$11,118,0001.37%
First Light Asset Management, LLC 955,505$12,498,0001.26%
GREAT POINT PARTNERS LLC 316,256$4,137,0001.00%
Rubric Capital Management LP 877,161$11,473,0000.58%
Avidity Partners Management LP 1,798,100$23,519,0000.48%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders